DK0946730T3 - Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse - Google Patents

Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse

Info

Publication number
DK0946730T3
DK0946730T3 DK97949733T DK97949733T DK0946730T3 DK 0946730 T3 DK0946730 T3 DK 0946730T3 DK 97949733 T DK97949733 T DK 97949733T DK 97949733 T DK97949733 T DK 97949733T DK 0946730 T3 DK0946730 T3 DK 0946730T3
Authority
DK
Denmark
Prior art keywords
spe
toxin
methods
vaccine
mutants
Prior art date
Application number
DK97949733T
Other languages
Danish (da)
English (en)
Inventor
Patrick M Schlievert
Douglas Ohlendorf
David T Mitchell
Pamala J Gahr
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of DK0946730T3 publication Critical patent/DK0946730T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK97949733T 1996-12-06 1997-12-05 Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse DK0946730T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3325196P 1996-12-06 1996-12-06

Publications (1)

Publication Number Publication Date
DK0946730T3 true DK0946730T3 (da) 2006-07-10

Family

ID=21869358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97949733T DK0946730T3 (da) 1996-12-06 1997-12-05 Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse

Country Status (14)

Country Link
US (1) US6835818B2 (de)
EP (1) EP0946730B1 (de)
JP (1) JP2002513278A (de)
KR (1) KR100615836B1 (de)
CN (1) CN1148449C (de)
AT (1) ATE319830T1 (de)
AU (1) AU734597B2 (de)
BR (1) BR9713679A (de)
CA (1) CA2273824C (de)
DE (1) DE69735439T2 (de)
DK (1) DK0946730T3 (de)
ES (1) ES2260804T3 (de)
PT (1) PT946730E (de)
WO (1) WO1998024910A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
US7491402B2 (en) 1998-12-24 2009-02-17 Auckland Uniservices Limited Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof
AU1648102A (en) * 2000-12-04 2002-06-18 Auckland Uniservices Ltd Immunomodulatory constructs and their uses
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
GB0227026D0 (en) * 2002-11-20 2002-12-24 Molecular Skincare Ltd Psoriasis diagnostics and therapeutics
US7299231B2 (en) * 2004-07-29 2007-11-20 International Business Machines Corporation Method and system of subsetting a cluster of servers
EP3411409B1 (de) 2016-01-10 2025-10-08 Neotx Therapeutics Ltd. Antikörper anti-pd-1/anti-pd-l1 zur stimulierung der durch superantigene vermittelten krebs immuntherapie
CN112449603A (zh) * 2018-05-16 2021-03-05 格里菲斯大学 链球菌中毒性休克综合征
AU2020275142A1 (en) 2019-05-15 2021-12-16 Neotx Therapeutics Ltd. Cancer treatment
JP2023517011A (ja) 2020-03-05 2023-04-21 ネオティーエックス セラピューティクス リミテッド 免疫細胞を用いて癌を治療するための方法および組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5336598A (en) * 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
US5298396A (en) * 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
CA2128415A1 (en) 1992-01-28 1993-08-05 John W. Kappler Protective effects of mutated superantigens
US5460813A (en) * 1993-04-05 1995-10-24 National Jewish Center For Immunology And Respiratory Medicine Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin
AU723116B2 (en) 1995-06-07 2000-08-17 Regents Of The University Of Minnesota Mutants of streptococcal toxin A and methods of use

Also Published As

Publication number Publication date
HK1024265A1 (en) 2000-10-05
JP2002513278A (ja) 2002-05-08
DE69735439D1 (de) 2006-05-04
ATE319830T1 (de) 2006-03-15
PT946730E (pt) 2006-06-30
KR100615836B1 (ko) 2006-08-25
DE69735439T2 (de) 2006-09-07
KR20000069337A (ko) 2000-11-25
US20020039585A1 (en) 2002-04-04
US6835818B2 (en) 2004-12-28
CA2273824C (en) 2007-05-08
ES2260804T3 (es) 2006-11-01
WO1998024910A3 (en) 1998-09-03
EP0946730A2 (de) 1999-10-06
CN1148449C (zh) 2004-05-05
AU734597B2 (en) 2001-06-21
CN1240001A (zh) 1999-12-29
CA2273824A1 (en) 1998-06-11
WO1998024910A2 (en) 1998-06-11
BR9713679A (pt) 2001-07-17
EP0946730B1 (de) 2006-03-08
AU7625698A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
DK0832241T3 (da) Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder
TR200901109T1 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
ATE382693T1 (de) Impfstoffe gegen neurotoxine von clostridium botulinum
ES2081370T3 (es) Gen y proteina de bacillus thuringiensis, y su utilizacion.
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
ATE490311T1 (de) Mutanten der alpha-amylase
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
PT946730E (pt) Mutantes de toxina estreptococica c e metodos de utilizacao
DE69735502D1 (de) Mutanten des lag-3 proteins, ihre expression und verwendung
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
DE69737032D1 (de) Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
HU9401949D0 (en) Expression signal-peptide-free staphylokinases
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
ATE186731T1 (de) Anomere fluorribosylamine
AU1720497A (en) Use of primers for universal fingerprint analysis
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
BR9611904A (pt) Dioxidos de ditiazol
SE9604439D0 (sv) New receptor